By Adrianne Appel2025-08-20T21:22:00
CVS’s Caremark division knowingly overcharged Medicare for prescription drugs and must pay nearly $290 million, a Pennsylvania federal judge has ordered.
Whistleblower Sara Behnke, a former Aetna employee, filed the suit in 2014, alleging that CVS was up-billing Medicare for drugs handled by CVS Caremark, a pharmacy benefit manager, an entity that processes prescription drug claims. The federal government later agreed to intervene and pursue the lawsuit.
2025-08-04T18:13:00Z By Adrianne Appel
The U.S. Department of Justice says the chief executive and medical director of Fast Lab Technologies allegedly engaged in a $500 million fraud scheme involving COVID-19 tests.
2025-05-15T14:45:00Z By Ian Sherr
UnitedHealth Group is being investigated by the Department of Justice for possible Medicare fraud, according to a report from the Wall Street Journal. The move, which has not so far been announced publicly, follows the sudden departure of its CEO.
2024-11-15T19:28:00Z By Adrianne Appel
A pharmaceutical company and its chief executive have agreed to pay $47 million to settle allegations first brought by whistleblowers, that the company paid kickbacks and filed false claims, the Department of Justice said.
2025-08-18T14:12:00Z By Oscar Gonzalez
The owner of a water machine vending company and a portfolio manager were allegedly behind a Ponzi-like scheme that raised more than $275 million, according to the U.S. Securities and Exchange Commission.
2025-08-15T18:59:00Z By Aly McDevitt
As regulators shift toward rewarding transparency, self-regulation and self-reporting, the way PFS Investments handled a longstanding problem serves as an example of how proactive remediation can turn a costly compliance error into a manageable regulatory outcome.
2025-08-15T18:26:00Z By Adrianne Appel
The Department of Justice says two Mexican businessmen living in Texas allegedly bribed Mexican officials to secure $2.5 million in contracts with Petróleos Mexicanos, Mexico’s state-owned oil company, and a subsidiary.
Site powered by Webvision Cloud